Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males.

NCT01471678 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Hyperplasia

Interventions

DRUG: Dutasteride (0.5mg)
DRUG: FDC product of dutasteride (0.5mg) and tamsulosin HCl (0.2mg)
DRUG: Harnal D Tablets and Harnal Capsules (both comprising 0.2 mg tamsulosin HCl)

Sponsor

GlaxoSmithKline